Plasma Exosomal RNA Biomarkers of High-Risk Prostate Cancer

Genomic classification (GC) in prostate cancer has demonstrated ability to distinguish patients with favorable disease from those most at risk of metastasis and cancer-related death. GC contributes to personalization of care by identifying subsets of patients for whom treatment intensification with radiation and hormonal therapy may be warranted. In treatment-naïve patients, risk stratification by standard clinical pathologic factors and GC can...